Pasireotide Extended-Release Injection and Vantrela ER
Determining the interaction of Pasireotide Extended-Release Injection and Vantrela ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: hydrocodone
Brand name: Hysingla ER, Vantrela ER, Zohydro ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Vaprisol
- Pasireotide Extended-Release Injection-Vaqta
- Pasireotide Extended-Release Injection-Vaqta Pediatric
- Pasireotide Extended-Release Injection-Vardenafil
- Pasireotide Extended-Release Injection-Vardenafil Hydrochloride
- Pasireotide Extended-Release Injection-Vardenafil ODT
- Vantrela ER-Pasireotide Injection
- Vantrela ER-Pasireotide Subcutaneous
- Vantrela ER-Patanase
- Vantrela ER-Patiromer
- Vantrela ER-Patiromer Sorbitex Calcium
- Vantrela ER-Pavacot